Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 30-2022

To publish the full text of the letter from the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
30
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 30-2022 (issued March 16, 2022) publishes the full text of a letter from FDA OIC-Director General Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The letter endorses medicines for cancer, diabetes, hypertension, high-cholesterol, mental illness and COVID-19 for inclusion in the List, one cancer medicine for delisting, and one COVID-19 medicine for correction.